GSK Investigational Site — Birmingham, Alabama

GSK Investigational Site is a clinical research site located in Birmingham, Alabama, United States 35215.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 264 clinical trials with 11 currently active.

Therapeutic areas: Bowel Dysfunction, Constipation, Hypertrophy, Left Ventricular.

Sponsors: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), GlaxoSmithKline, ViiV Healthcare.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 264 clinical trials on record, with 11 currently active. Their work covers Bowel Dysfunction, Constipation, Hypertrophy, Left Ventricular.

Is GSK Investigational Site accredited by Crixeo Health?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.